Edward Fox from the MS Clinic of Central Texas: Alemtuzumab’s Long-Term Studies Show Efficacy for Multiple Sclerosis Treatment

                                                                  

Click here to receive MS news via e-mail        
 

Apr 19, 2016    |    Adam Hochron – 

With a unique delivery method, alemtuzumab (Lemtrada) has proven to be an effective treatment option for multiple sclerosis. While careful monitoring is required, new data has shown benefits for the right patient population.


Watch this video presentation

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
MS Views and News
Provides educational information, resources and services for those affected by MS
We Believe YOU (the MS Patients and Caregivers) should Be Empowered with Multiple Sclerosis information
.===================================